UPCC 23217: A Phase 1b/2 Study ofBMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors
Enrolling By Invitation
99 years or below
All
5 participants needed
1 Location
Brief description of study
TBD
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: ['Colorectal Cancer', 'Pancreatic Cancer']
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 828240
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu
